Tradewinds Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
FDCDDQ
DBIA
Tradewinds Capital Management's PJP Position: Q2 2022 in Review
Tradewinds Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2022, closing a stake of 107 shares — an estimated $9K sold.
Tradewinds Capital Management first reported a position in PJP in Q4 2013 and held it in 34 quarters. The position peaked at $46K in Q3 2018. 79 funds tracked by Wall St. Rank hold PJP as of Q2 2022.
- Tradewinds Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2022 after selling out during the quarter.
- Tradewinds Capital Management sold 107 Invesco Pharmaceuticals ETF shares in Q2 2022, an estimated $9K.
- Tradewinds Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2013 and held it in 34 quarters.
- Tradewinds Capital Management's Invesco Pharmaceuticals ETF position peaked at $46K in Q3 2018.
- 79 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2022.
Based on Tradewinds Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.